Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?


Autoria(s): Grouzmann E.; Buclin T.
Data(s)

2008

Identificador

http://serval.unil.ch/?id=serval:BIB_A6FECBCB5AC9

isbn:1524-4563[electronic]

pmid:18025291

doi:10.1161/HYPERTENSIONAHA.107.101329

isiid:000251774400013

Idioma(s)

en

Fonte

Hypertension, vol. 51, no. 1, pp. 45-7

Palavras-Chave #Angioedema/chemically induced; Angioedema/enzymology; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Antigens, CD26/antagonists & inhibitors; Antigens, CD26/metabolism; Bradykinin/metabolism; Enzyme Inhibitors/therapeutic use; Humans; Hypertension/drug therapy; Neprilysin/metabolism; Peptidyl-Dipeptidase A/metabolism; Substance P/metabolism
Tipo

info:eu-repo/semantics/article

article